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Abstract
The experiments carried out on 13 white rats focused on the study of the influence of enterosorption, hyperbaric oxygen therapy and their 
association upon the intensity of the antioxidant system in the liver in acute toxic hepatitis induced by tetrachlormethane.  Analysis of the results 
revealed that acute toxic hepatitis leads to some insignificant disorders of the antioxidant system in the liver which manifest as a reduction in the 
level of superoxide-dismutase (SOD), catalase, gamma-glutamyl transpeptidase and an increase in the amount of glutathione-reductase.  The 
medicinal charcoal and Medicas E enterosorbent contribute to restoration of the above mentioned disturbances, mainly when used for 14 days. 
Enterosorption in association with hyperbaric oxygen therapy reduces the activity of gamma-glutamyl transpeptidase which is accompanied by 
indirect changes of SOD, catalase and glutathione-reductase activity.
Key words: enterosorption, hyperbaric oxygen therapy, toxic hepatitis, antioxidant system.
Антиоксидантная система при экспериментальном токсическом гепатите под влиянием энтеросорбции, гипербарической 
оксигенации и их ассоциации
В опытах, осуществляемых на 130 белых крысах, было изучено влияние энтеросорбции, гипербарической оксигенации и 
их комбинации на интенсивность антиоксидантной системы в печени при остром токсическом гепатите индуцированным 
тетрахлорметаном.  В результате анализа полученных данных было установлено, что острый токсический гепатит приводит к 
несущественным нарушениям антиоксидантной системы в печени, которые проявляются снижением уровня супероксиддисмутазы, 
каталазы, гамма-глутамилтранспептидазы и увеличением глютатионредуктазы.  Активированный уголь и энтеросорбент Медикас 
Е способствуют восстановлению обнаруженных нарушений, в частности, при использовании в течение 14 дней.  Энтеросорбция в 
сочетании с гипербарической оксигенацией приводят к снижению активности гамма-глютамилтранспептидазы, которая сопровождается 
непрямыми изменениями активности супероксиддисмутазы, каталазы и глютатионредуктазы.
Ключевые слова: энтеросорбция, гипербарическая оксигенация, токсический гепатит, антиоксидантная система.
Introduction
Oxidative stress represents metabolic disturbances by free 
oxygen radicals both on the cellular and systemic level.  It mani-
fests as an imbalance in the pro- and antioxidant systems, either 
through excessive formation of free radicals or consumption of 
the antioxidant capacity of the body.  The majority of patholo-
gical processes are characterized by involvement of the pro- and 
antioxidant system, thus further research of these processes is 
justified in attempts to understand natural physiological recovery 
as well as therapeutic antioxidant remedies.  The liver, due to its 
role in metabolizing exogenous and endogenous compounds, is 
subjected to a continuous oxidative stress which results in me-
tabolic and structural changes of the hepatic tissue with marked 
impairment of function [2, 3, 4, 5, 7].
Stabilization of balance between generation of reactive 
oxygen species (ROS) and antioxidant protection represents 
a crucial factor in prophylaxis of a disease with chronic evolu-
tion.  Antioxidants inhibit oxidative processes and neutralize 
free radicals.  They can block initiation and maintenance 
of oxidative processes, as well as interfere with the chain 
of reactions through which new free radicals are produced 
(for example, peroxidation of cellular membrane lipids or of 
lipoproteins).
There is a negative correlation between the content of the 
secondary products of ROS and enzymatic activity of the anti-
oxidant system.  Disturbance of the above mentioned balance 
leads to acceleration of the reaction of peroxide oxidation 
of lipids in biologic membranes and represents one of the 
fundamental factors in pathogenesis of multiple pathological 
conditions: hepatotoxicity, hyperoxia, hypoxia, hyper- and 
hypothermia, ischemia, inflammations etc. [8].
Due to various direct and indirect mechanisms, ente-
rosorption has a wide use in medical practice, including 
complex treatment of hepatic diseases.  Toxic diseases of 
the liver, caused by xenobiotics (industrial toxic substances, 
medicines etc.) have a considerable impact on occurrence of 
hepatic diseases.  Carbon tetrachloride (CCl4) represents one 
of the most widely spread harmful substances occurring in 
different domains of industry which can cause hepatic lesions 
in people exposed to it.  It has been established that through 
administration of carbon tetrachloride in toxic hepatitis, 
enterosorption contributes to a considerable reduction of 
the intermediate and final products of lipid peroxidation 
(dienic conjugates and malonic dialdehyde), as well as to the 
correction of the activity of superoxide-dismutase, catalase, 
glutathione-reductase, glutathione peroxidase, phospholipid 
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concentration, alpha-tocopherol, ceruloplasmin, ascorbic 
acid and retinol [8].
Enterosorbents including activated charcoal have proved 
their importance in the complex treatment of both experi-
mental and clinical hepatitis of various etiologies. (V. Gonciar, 
2008, L. Baxan, 2006).
The purpose of the work is to assess the influence of en-
terosorption, hyperbaric oxygen therapy (HBOT) and their 
association in evolution of the antioxidant system in the liver 
in acute toxic hepatitis.
Material and methods
Experiments have been carried out on 130 white rats, 
10 in each group, with a body weight of 180-220 gr.  Toxic 
hepatitis was induced by subcutaneous administration of 
carbon tetrachloride during 4 days in dosage of 0.4 ml/100gr. 
Enterosorbents - medicinal charcoal (MC) and Medicas E 
sorbent were used in dosage of 50 mg/100gr, administered 
intragastric, for 7 and 14 days.  Animals were divided into 13 
groups: 1 - control, 7 days; 2 - CCl4, 7 days; 3 - CCl4, 14 days; 
4 - CCl4 + medicinal charcoal, 7 days, 5 - CCl4 + medicinal 
charcoal, 14 days; 6 - CCl4 + Medicas E, 7 days; 7 - CCl4 + 
Medicas E, 14 days; 8 - HBOT (2026 kPa - 60min.) – sessi-
ons; 9 – HBOT (2026 kPa – 60 min.) – 10 sessions (14 days); 
10 - HBOT (2026 kPa – 60 min.) 7 sessions + CM 7 days; 
11 – HBOT (2026 kPa – 60 min.) 10 sessions + MC, 14 days; 
12 - HBOT (2026 kPa – 60 min.), 7 sessions + Medicas E, 7 
days; 13 - HBOT (2026 kPa – 60 min.), 10 sessions + Medicas 
E, 14 days.  The rats were euthanized on the 8th and 15th day, 
and their liver was collected for biochemical studies.  The 
results of investigations were subjected to statistical analysis, 
using “t-Student”.
Activity of the following enzymes has been determined 
in the collected liver: superoxide-dismutase (SOD), cata-
lase (CT), gamma-glutamyl transpeptidase (y-GTP) and 
glutathione reductase (GR) using the immunoenzymatic 
method.
Results and discussions
The activity of the antioxidant system: Superoxide-Dis-
mutase (SOD), catalase (CT), gamma-glutamyl transpepti-
dase (y-GTP) and glutathione reductase (GR) is shown in 
the table.  After injecting CCl4 for 4 days, on the 7th day a 
reduction of SOD activity was seen from 9.06 ± 0.53 to 8.41 
± 3.78 (with 7,18%, p > 0.005), but it increased again on the 
14th day from 9.06 ± 0.53 to 13.15 ± 1.02 (with 45.1%, p < 
0.05).  Similar data concerning reduction of SOD activity in 
the liver were reported by Lee M. K. et al. (2009); Sindhu E. 
R. et al. (2010); Akindele A. J. et al., (2010); Murzaahmedova 
A. A. et al. (2010).
Use of MC in animals with toxic hepatitis for one week 
did not reveal essential changes of SOD activity compared 
with the control group, while use of activated charcoal for 14 
days contributed to restoring the SOD enzyme levels in rats, 
as compared to the control group (tab. 1).  Administration of 
Medicas E sorbent during 7 days reduced SOD activity from 
9.06 ± 0.53 to 7.06 ± 1.02 (22.1%, p > 0.05), but on the 14th 
day an increase was again seen from 9.06 ± 0.53 up to 12.68 
± 0.96 (14%, p < 0.05).
Administration of hyperbaric oxygen therapy for 7-10 
sessions in animals with acute toxic hepatitis showed a 3.5-5 
fold intensification of SOD activity.  It is relevant that associ-
ation of HBOT with MC and Medicas E causes an increase of 
activity of the respective enzyme both at early and late stages 
of the hepatic disease.  We can conclude that proper use of 
hyperbaric oxygen enhances the activity of the enzymatic 
antioxidant system both for annihilation of ROS induced by 
hepatotoxic substances and for neutralizing superoxide anion 
formed from HBOT effect.
Experimental hepatitis does not change significantly the 
activity of catalase in the liver. Similar findings have been 
described by Lee M. K. et al. (2009); Login C.(2009); Sindhu 
E. R. et al. (2010); Akindele A. J.et al., (2010).  Administrati-
on of CCl4 on the 8th day revealed an intensification of GR 
activity in the liver from 3.56 ± 0.15 to 4.59 ± 0.34 (29%, p 
< 0.05), subsequently it returned to the baseline level of the 
control animals (day 14).  Collected data are in accordance 
with the data from the literature [3].  Under these conditions 
a reduction of the catalase/glutathione reductase ratio (CT/
GR) was seen from 0.23 to 0.15 at early stage of the hepatic 
disease with an increase up to 0.2 at late stage.
Use of MC and Medicas E adsorbent for the duration of 
one week causes a significant reduction of catalase activity 
in the liver, however it returns to control levels after 14 days 
of treatment.  Medicinal charcoal used in the treatment of 
rats with experimental hepatitis for 1 and 2 weeks did not 
significantly influence GR activity in the liver compared with 
the control group, but it diminished the effect of hepatotoxic 
substance at an earlier stage of the hepatic affliction.  In such 
conditions the treatment with Medicas E adsorbent for 7 days 
contributed to an increase of GR in the liver from 3.56 ± 0.15 
up to 4.39 ± 0.17 (23%, p < 0.001) as compared with the control 
group.  Use of this enterosorbent for 14 days in the experi-
mental group was associated with an increase in antioxidant 
enzyme levels comparable to the levels in the control group. 
There was a significant reduction of CT/GR proportion on 
the 8th day of treatment with MC and Medicas E to 0.12 and 
0.1 respectively.  Subsequently this proportion was restored 
to control levels after 2 weeks of treatment.
  At the early stage of the hepatic lesion an increase in lipid 
peroxidation exhausts the detoxification pathway of gluta-
thione-peroxidase with the ultimate production of oxidized 
glutathione(GSSG).  In such conditions, GR activity increases 
with the restoration of glutathione (GSH) quantity.  In later 
stages of hepatotoxicity activated charcoals, through elimina-
tion of toxic products of CCl4, likely contribute to the removal 
of tissue hypoxia with restoration of catalase and GR activity, 
expressed through normalization of CT/GR proportion.
Exposure of rats with hepatic diseases to hyperbaric 
oxygen for curative reasons (7 and 10 sessions) reduced cata-
lase activity in the liver with an increase of GR activity from 
3.56 ± 0.15 to 7.64 ± 0.77 (114%, p < 0.001) after 7 sessions 
and from 3.56 ± 0.15 to 9.75 ± 0.77 (173%, p < 0.001) after 10 
sessions of HBOT.  In such conditions an important reduction 
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of CT/GR proportion was seen after 7 and 14 days to 0.053 and 
0.054, respectively, compared with the control group (0.23) 
and experimental groups 2 and 3 (0.15 and 0.2).
In case of co-administration of HBOT and MC for 7 days, 
the content of catalase in the liver diminished compared with 
both the control group and the CCL4 experimental group 
(CCl4 – 7 days).  Combined treatment with MC and HBOT (10 
sessions) contributed to an increase of catalase activity com-
pared with the group that received only hyperbaric oxygen. 
During the concomitant use of Medical E with hyperbaric 
oxygen for 7 and 14 days catalase activity was at the level of 
the group treated with HBOT.
Associated treatment of acute toxic hepatitis with MC 
and Medical E during 1 and 2 weeks contributed to a marked 
increase of GR in the liver (table 1).  In these conditions we 
determined an essential reduction of CT/GR proportion, whi-
ch constituted 0.055 in the group subjected to MC + HBOT 
for 7 sessions, 0.11 – MC + HBOT for 10 sessions, 0.074 – 
Medicas E + HBOT for 7 sessions and 0.059 – Medicas E + 
HBOT 10 sessions.
During modeling of acute toxic hepatitis there was a re-
duction of y – GTP activity in the liver from 0.243 ± 0.07 to 
0.197 ± 0.003 (19%, p > 0.05) on the 8th day and to 0.217 ± 0.01 
(10.7%, p > 0.05) on the 15th day.  Having administered MC 
for one week, a significant increase in the antioxidant enzymes 
in the liver was observed, as compared with the  CCl4-only 
experimental group , whereas no significant difference was 
observed with the control group.  At the same time, while 
using activated charcoal for 14 days, a decrease of gamma-GTP 
activity was seen as compared with the control animals, from 
0.217 ± 0.01 to 0.123 ± 0.02 (43.4%, p < 0.05).  Similar effects 
have been revealed when using Medicas E for 7 and 14 days.
Hyperbaric oxygen therapy (7 and 10 sessions) in rats with 
acute toxic hepatitis was associated with marked reduction of 
Table 1
Activity of antioxidant system in the liver of rats with acute toxic hepatitis under  
the influence of enterosorption, oxygen-baric therapy and their association
Nr. 
gr. Conditions of experiment 
SOD, M ± m
u/g. prot.
Gama - GTP, M ± m
u/s. g. prot.
GR, M ± m
µmol/s. g. prot.
CT, M ± m
µmol/s. g. prot.
1. Witness group   9.06 ± 0.53 0.243 ± 0.07 3.56 ± 0.15 0.81 ± 0.05
2. CCl4 – 7 days (control)   8.41 ± 3.78 0.197 ± 0.003 4.59 ± 0.34* 0.71 ± 0.1
3. CCl4 – 14 days 13.15 ± 1.02* 0.217 ± 0.01   3.8 ± 0.22 0.79 ± 0.05
4. CCl4 + CM – 7 days   8.46 ± 1.1 0.298 ± 0.025** 3.74 ± 0.23 0.45 ± 0.02*
5. CCl4 + CM  – 14 days     9.0 ± 0.94** 0.123 ± 0.02***   3.9 ± 0.26 0.96 ± 0.08***
6. CCl4 + Medicas E – 7 days   7.06 ± 1.02 0.321 ± 0.006** 4.39 ± 0.17* 0.46 ± 0.03* **
7. CCl4 + Medicas E – 14 days 12.68 ± 0.96**** 0.132 ± 0.013*** 3.69 ± 0.27*** 0.98 ± 0.05****
8. CCl4 + OBT – 7 days 32.49 ± 2.55* ** 0.048 ± 0.009*** 7.64 ± 0.77* ** 0.41 ± 0.03* **
9. CCl4 + OBT – 14 days 47.39 ± 3.29* ** 0.059 ± 0.005*** 9.75 ± 0.77* ** 0.57 ± 0.05* **
10. CCl4 + CM + OBT – 7 days 35.67 ± 1.24****** 0.047 ± 0.002****** 7.56 ± 0.47****** 0.41 ± 0.03* **
11. CCl4 + CM + OBT– 14 days 49.23 ± 2.68****** 0.061 ± 0.002****** 8.63 ± 0.3****** 0.97 ± 0.17
12. CCl4 + Medicas E + OBT – 7 days 42.16 ± 3.76****** 0.051 ± 0.004****** 7.14 ± 0.55****** 0.53 ± 0.05*
13. CCl4 + Medicas E + OBT – 14 days 41.09 ± 2.77****** 0.108 ± 0.055*** 9.55 ± 1.23****** 0.57 ± 0.07******
Note: * - statistically significant with the control group (1); ** - statistically significant with CCl4 + respective preparation (4 and 6).
gamma-GTP activity in the liver.  While using concomitantly 
hyperbaric oxygen and activated charcoal (MC and Medicas 
E) the activity of the respective enzyme was twice or five times 
less than in the CCl4 only group and control group.  Thus, 
activated charcoals and oxygen under pressure manifested an 
effect which is opposite to the hepatotoxic substance at early 
and late stages, but during the association of the therapeutic 
agents the effect of the hyperbaric oxygen predominated.
Thus, changes of enzymes of the antioxidant system are de-
pendent on the early or late evolution of the hepatic disease.  At 
early stage activation of processes of lipids peroxidation takes 
place (increase of DAM and HPL), involving the enzymes of 
antioxidant system.  Later, in untreated animals, there was an 
initiation of the processes of correction of the oxidative stress 
marked by a reduction of ROS products and an increase of an-
tioxidant enzyme activity.  Carbon tetrachloride (CCl4), being 
a lipophilic substance, a relatively non-reactive molecule, can 
cross the membrane of hepatocytes becoming more toxic after 
enzymatic activation on the level of the smooth endoplasmatic 
reticulum.  CCl4 is metabolized in the microsomes where it is 
reduced by the P450 cytochrome resulting in the formation of 
free radicals: trichlormethyl (CCL3) and peroxichlormethyl 
(OOCCl3), which subsequently attack the lipid structures of 
the cellular membranes, leading to their peroxidation [4].
Metabolization of CCl4 depends on the presence or ab-
sence of oxygen.  During the reduction of concentration or 
absence of oxygen (hypoxia, including that induced by the 
hepatoxic substance), the enzymes of P450 cytochrome me-
tabolize the whole quantity of CCl4 producing CCl3, which 
overcomes the antioxidant capacity of the liver, ultimately 
harming lipid membrane structures..  In anaerobic conditi-
ons CCl4 can also metabolize in an alternative way, forming 
products of carbyne type, which attach to proteins and nucleic 
acids.  When there is a sufficient supply of molecular oxygen, it 
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inhibits cytochrome P450 and respectively inhibits formation 
of CCl3.  Based on other literature, we suppose that CCl4 exerts 
a hepatotoxic effect through several mechanisms.  One of them 
is lipid peroxidation.  Supporting this is the correlation that 
exists between the increase of transaminases in the serum 
and the products of lipid peroxidation in the liver, primarily 
the increase of malonic dialdehyde.  Hepatotoxicity of CCl4 
manifests through formation of free radicals CCl3, OOCCl4 
and Cl that act upon membranous lipids by triggering lipid 
peroxidation (POL) responsible for physiologic functions of 
the membranes, bioenergetic processes and finally for the 
cellular functions.
The therapeutic effect of enterosorption, including that of 
activated charcoal (MC and Medicas E), in acute toxic hepati-
tis  induced with CCl4, can be explained by interference with 
absorption of unsaturated fatty acids (a source of lipoperoxi-
dation), biliary acids and toxins, as well as the intermediate 
products eliminated through bile in the intestine (CCl4, CCl3 
etc.), as well as other POL products.
Hyperbaric oxygen, by increasing partial pressure of 
oxygen and inhibition of P450 cytochrome activity (especi-
ally isomorphs 3A4 and 2E1), contributes to diminishing the 
formation of CCl3 and its transformation into a less reactive 
OOCCl3.  HBOT, through reduction of tissue hypoxia induced 
by the hepatotoxic substance, probably diminishes the alterna-
tive pathway of CCl4 metabolization with carbyne formation, 
reducing subsequent consequences.  Simultaneously, oxygen 
under pressure in curative ways intensifies significantly SOD 
activity in the liver, thus intensifying enzymatic inactivation 
of SRO (superoxide anion etc.).  This effect of HBOT is syner-
gistic with enterosorption, a phenomenon of enhancement of 
beneficial effects of the therapeutic agents, leading to accele-
rated hepatocytes restructuring and functional remodeling.
Conclusions
1. Some insignificant changes of the antioxidant system 
activity in the liver occur in acute toxic hepatitis induced by 
CCl4; the changes manifest through reduction of the level of 
SOD, catalase, gamma-GTP and an increase of GR.
2. Medicinal charcoal and enterosorbent Medicas E do 
not influence significantly the enzymes of the antioxidant 
system while being used for 7 days, but they can contribute to 
the restoration of the revealed disturbances, especially while 
being used for 14 days.
3. Enterosorption in association with oxygen-baric therapy 
reduce y-GTP activity accompanied by reverse changes in 
activity of SOD, catalase and GR.
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